Cargando…

Hemodialysis-Related Vision Loss from Anterior Ischemic Optic Neuropathy

Vision loss from nonarteritic anterior ischemic optic neuropathy (NAION) is a rare complication of hemodialysis. Here, we present a case in a young woman and discuss the pathophysiology and implications for the nephrologist. A 24-year-old woman with end-stage renal disease developed unilateral, pain...

Descripción completa

Detalles Bibliográficos
Autores principales: Eshtiaghi, Arshia, Micieli, Jonathan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082139/
https://www.ncbi.nlm.nih.gov/pubmed/35611025
http://dx.doi.org/10.1159/000523985
_version_ 1784703143146160128
author Eshtiaghi, Arshia
Micieli, Jonathan A.
author_facet Eshtiaghi, Arshia
Micieli, Jonathan A.
author_sort Eshtiaghi, Arshia
collection PubMed
description Vision loss from nonarteritic anterior ischemic optic neuropathy (NAION) is a rare complication of hemodialysis. Here, we present a case in a young woman and discuss the pathophysiology and implications for the nephrologist. A 24-year-old woman with end-stage renal disease developed unilateral, painless vision loss following treatment with hemodialysis. Fundoscopy revealed severe left inferior chalky-white opticdisc edema, a presentation consistent with NAION. Her intradialytic blood pressure was reviewed and found to be significantly lower than her baseline, and a multidisciplinary meeting took place between her ophthalmologist and nephrologist to modify her dialysis sessions to minimize the chance of progression or involvement of her fellow eye. At the 2-month follow-up, the opticdisc edema resolved, and her visual function remained stable. Overall, NAION is a rare complication of hemodialysis and may be a result of intradialytic hypotension, platelet and endothelial dysfunction, anemia, and accumulations of toxins such as urea. As there are no established treatments for NAION, management should focus on optimizing modifiable risk factors to prevent further vision loss in the other eye. These factors include increasing the number of dialysis sessions and duration of sessions, reducing the temperature of the dialysate, discouraging eating, and increasing the dialysate's calcium concentration. Prompt recognition of NAION and multidisciplinary teamwork can minimize the risk of NAION progression and involvement of the contralateral eye.
format Online
Article
Text
id pubmed-9082139
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-90821392022-05-23 Hemodialysis-Related Vision Loss from Anterior Ischemic Optic Neuropathy Eshtiaghi, Arshia Micieli, Jonathan A. Case Rep Nephrol Dial Single Case Vision loss from nonarteritic anterior ischemic optic neuropathy (NAION) is a rare complication of hemodialysis. Here, we present a case in a young woman and discuss the pathophysiology and implications for the nephrologist. A 24-year-old woman with end-stage renal disease developed unilateral, painless vision loss following treatment with hemodialysis. Fundoscopy revealed severe left inferior chalky-white opticdisc edema, a presentation consistent with NAION. Her intradialytic blood pressure was reviewed and found to be significantly lower than her baseline, and a multidisciplinary meeting took place between her ophthalmologist and nephrologist to modify her dialysis sessions to minimize the chance of progression or involvement of her fellow eye. At the 2-month follow-up, the opticdisc edema resolved, and her visual function remained stable. Overall, NAION is a rare complication of hemodialysis and may be a result of intradialytic hypotension, platelet and endothelial dysfunction, anemia, and accumulations of toxins such as urea. As there are no established treatments for NAION, management should focus on optimizing modifiable risk factors to prevent further vision loss in the other eye. These factors include increasing the number of dialysis sessions and duration of sessions, reducing the temperature of the dialysate, discouraging eating, and increasing the dialysate's calcium concentration. Prompt recognition of NAION and multidisciplinary teamwork can minimize the risk of NAION progression and involvement of the contralateral eye. S. Karger AG 2022-03-29 /pmc/articles/PMC9082139/ /pubmed/35611025 http://dx.doi.org/10.1159/000523985 Text en Copyright © 2022 by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Single Case
Eshtiaghi, Arshia
Micieli, Jonathan A.
Hemodialysis-Related Vision Loss from Anterior Ischemic Optic Neuropathy
title Hemodialysis-Related Vision Loss from Anterior Ischemic Optic Neuropathy
title_full Hemodialysis-Related Vision Loss from Anterior Ischemic Optic Neuropathy
title_fullStr Hemodialysis-Related Vision Loss from Anterior Ischemic Optic Neuropathy
title_full_unstemmed Hemodialysis-Related Vision Loss from Anterior Ischemic Optic Neuropathy
title_short Hemodialysis-Related Vision Loss from Anterior Ischemic Optic Neuropathy
title_sort hemodialysis-related vision loss from anterior ischemic optic neuropathy
topic Single Case
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082139/
https://www.ncbi.nlm.nih.gov/pubmed/35611025
http://dx.doi.org/10.1159/000523985
work_keys_str_mv AT eshtiaghiarshia hemodialysisrelatedvisionlossfromanteriorischemicopticneuropathy
AT micielijonathana hemodialysisrelatedvisionlossfromanteriorischemicopticneuropathy